Key Takeaways
- • SpaceX-Cursor Deal: Elon Musk's SpaceX has struck a deal with artificial intelligence startup Cursor that could lead to an acquisition, expanding SpaceX's AI capabilities.
- • QXO Acquires TopBuild: Building products distributor QXO Inc. has completed a significant acquisition of TopBuild Corp., consolidating positions in the building supply sector.
- • Eli Lilly Biotech Acquisition: Pharmaceutical giant Eli Lilly & Co. has acquired Kelonia Therapeutics, a clinical-stage biotechnology company, bolstering its pipeline in therapeutic development.
- • Tax and Legal Implications: The three transactions highlight the intersection of M&A activity and tax structuring considerations, addressed through coverage in the "Taxation With Representation" series.
Summary
This week's M&A activity encompasses three notable transactions across aerospace, building products, and biopharmaceuticals sectors. SpaceX, owned by Elon Musk, has entered into a deal with Cursor, an artificial intelligence startup, with the potential to evolve into a full acquisition. This move reflects broader industry trends toward integrating AI capabilities into established technology and aerospace platforms.
In the building products space, QXO Inc., a distributor focused on construction materials, has acquired TopBuild Corp., representing consolidation within the residential and commercial construction supply chain. This transaction expands QXO's market footprint and product portfolio in a sector tied to housing and infrastructure activity.
Eli Lilly & Co. has acquired Kelonia Therapeutics, a clinical-stage biotech firm, continuing the pharmaceutical industry's strategy of external innovation through strategic acquisitions. Such deals allow large-cap pharma companies to accelerate pipeline development and expand their therapeutic offerings.
The coverage of these transactions through the "Taxation With Representation" column, authored by Zak Kostro and published on Law360 on April 24, 2026, indicates focus on the tax structuring and legal implications underlying each deal. These transactions demonstrate continued institutional M&A activity across diversified sectors despite broader economic conditions, with particular emphasis on how companies structure acquisitions to optimize tax outcomes and regulatory compliance.
In the building products space, QXO Inc., a distributor focused on construction materials, has acquired TopBuild Corp., representing consolidation within the residential and commercial construction supply chain. This transaction expands QXO's market footprint and product portfolio in a sector tied to housing and infrastructure activity.
Eli Lilly & Co. has acquired Kelonia Therapeutics, a clinical-stage biotech firm, continuing the pharmaceutical industry's strategy of external innovation through strategic acquisitions. Such deals allow large-cap pharma companies to accelerate pipeline development and expand their therapeutic offerings.
The coverage of these transactions through the "Taxation With Representation" column, authored by Zak Kostro and published on Law360 on April 24, 2026, indicates focus on the tax structuring and legal implications underlying each deal. These transactions demonstrate continued institutional M&A activity across diversified sectors despite broader economic conditions, with particular emphasis on how companies structure acquisitions to optimize tax outcomes and regulatory compliance.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.